Metagenomi Therapeutics, Inc.

MGX·NASDAQ·$1.36Share Price as of 11/2·$51MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/10/26 10-QQ1 ended 03/31/2605/11/26 10-KFY 202503/05/26 10-QQ3 ended 09/30/2511/12/25 10-QQ2 ended 06/30/2508/12/25

Disclosures

8-KCurrent report09/22/26 8-KCurrent report08/10/26 8-KCurrent report06/10/26 8-KCurrent report05/11/26 8-KCurrent report03/05/26

Prospectuses and Registrations

S-8Registration of securities for employees03/05/26 S-3Shelf registration03/17/25 S-8Registration of securities for employees03/17/25 424B4Prospectus02/12/24 S-8Registration of securities for employees02/09/24

Proxies

DEF 14ADefinitive proxy04/27/26 DEFA14AAdditional proxy materials04/27/26 DEF 14ADefinitive proxy04/28/25 DEFA14AAdditional proxy materials04/28/25

Ownership

Form 4Insider transaction09/11/26 Form 4Insider transaction09/10/26 Form 4Insider transaction09/10/26 Form 4Insider transaction09/10/26 SC 13GBeneficial ownership09/10/26

Other

ARSAnnual report to shareholders04/27/26 ARSAnnual report to shareholders04/28/25 EFFECTRequest for effectiveness03/25/25 CORRESPCorrespondence with the SEC03/21/25 UPLOADLetter from the SEC03/21/25